Rabeprazole Sodium Tablet, Delayed Release
Product Images NDC 76420-818

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rabeprazole Sodium (NDC 76420-818). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Rabe-str (Rabe Str)

Chemical structure diagram of Rabeprazole Sodium showing its molecular arrangement, including nitrogen, sulfur, oxygen, and sodium atoms, consistent with its chemical composition as a proton pump inhibitor.*

FDA Label Image

Rabe-str2 (Rabe Str2)

A line graph showing mean heartburn scores over a 28-day study period comparing placebo, Rabeprazole (RAB) 10 mg, and Rabeprazole 20 mg groups. The vertical axis represents mean scores from 0 (none) to 4 (very severe), and the horizontal axis shows study days from -14 to 28. The graph shows a decline in heartburn severity after day 0, with the 20 mg dosage having the lowest mean scores.*

FDA Label Image

Rabe-str3 (Rabe Str3)

A line graph comparing mean heartburn scores over 28 study days between placebo (dashed line) and Rabeprazole Sodium 20 mg (solid line) groups. The y-axis represents mean scores from 0 (none) to 4 (very severe). Scores decrease more notably after day 0 in the Rabeprazole group compared to placebo.*

FDA Label Image

Rabe-str4 (Rabe Str4)

A line graph depicting mean heartburn scores over study days for a placebo group and a Rabeprazole Sodium 20 mg group. The x-axis represents study days from -14 to 28, and the y-axis shows mean scores from 0 (None) to 4 (Very Severe). The Rabeprazole 20 mg group consistently has lower mean heartburn scores compared to placebo, particularly after day 0.*

FDA Label Image

Label (Label)

Labels for Rabeprazole Sodium delayed-release tablets 20 mg by Enovachem Pharmaceuticals, relabeled and packaged by Asclemed USA, Inc. The labels show 30, 60, and 90 tablet quantities with NDC codes 76420-818-30, 76420-818-60, and 76420-818-90 respectively. They include distribution and storage information along with caution statements.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.